医疗设备：适应比较疗效格局。
Medical devices: adapting to the comparative effectiveness landscape.
作者信息
Mohandas Anita, Foley Kathleen A
出版信息
Biotechnol Healthc. 2010 Summer;7(2):25-8.
Abstract
Outcomes research for medical devices has always lagged, with good reason. Comparative effectiveness initiatives, though, will soon spur demand for more and better data, and that means more and better outcomes research training.
摘要
医疗器械的疗效研究一直滞后，这是有充分理由的。不过，比较疗效倡议很快将刺激对更多、更好数据的需求，这意味着需要更多、更好的疗效研究培训。
相似文献
1
Medical devices: adapting to the comparative effectiveness landscape.医疗设备：适应比较疗效格局。
Biotechnol Healthc. 2010 Summer;7(2):25-8.
2
Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation.
J Comp Eff Res. 2018 Feb;7(2):167-175. doi: 10.2217/cer-2017-0059. Epub 2018 Feb 21.
3
Nanotechnology: an evidence-based analysis.纳米技术：基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 1.
4
Methodological considerations in observational comparative effectiveness research for implantable medical devices: an epidemiologic perspective.植入式医疗器械观察性比较效果研究中的方法学考量：流行病学视角
Am J Epidemiol. 2014 Nov 1;180(9):949-58. doi: 10.1093/aje/kwu206. Epub 2014 Sep 25.
5
A systematic review of serious games in medical education: quality of evidence and pedagogical strategy.医学教育中严肃游戏的系统评价：证据质量和教学策略。
Med Educ Online. 2018 Dec;23(1):1438718. doi: 10.1080/10872981.2018.1438718.
6
Comparative effectiveness research under the Patient Protection and Affordable Care Act: can new bottles accommodate old wine?《患者保护与平价医疗法案》下的比较效果研究：新瓶装旧酒？
Am J Law Med. 2011;37(4):522-66. doi: 10.1177/009885881103700402.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Supporting Imagers' VOICE: A National Training Program in Comparative Effectiveness Research and Big Data Analytics.支持影像医师的声音：一个在比较效果研究和大数据分析方面的国家级培训项目。
J Am Coll Radiol. 2018 Oct;15(10):1451-1454. doi: 10.1016/j.jacr.2017.09.023. Epub 2017 Dec 6.
9
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树：影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
10
Ethical pitfalls in neonatal comparative effectiveness trials.新生儿比较疗效试验中的伦理陷阱。
Neonatology. 2014;105(4):350-1. doi: 10.1159/000360650. Epub 2014 May 30.
引用本文的文献
1
Comparison of devices used to measure blood pressure, grip strength and lung function: A randomised cross-over study.比较用于测量血压、握力和肺功能的设备：一项随机交叉研究。
PLoS One. 2023 Dec 27;18(12):e0289052. doi: 10.1371/journal.pone.0289052. eCollection 2023.
2
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty.医疗器械经济评估证据水平的系统评价：椎体成形术和后凸成形术的实例
PLoS One. 2015 Dec 10;10(12):e0144892. doi: 10.1371/journal.pone.0144892. eCollection 2015.
本文引用的文献
1
Modernizing device regulation.使设备监管现代化。
N Engl J Med. 2010 Apr 1;362(13):1161-3. doi: 10.1056/NEJMp1000447. Epub 2010 Mar 24.
2
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).紫杉醇洗脱支架的长期安全性和有效性：TAXUS IV 临床试验的 5 年最终结果（TAXUS IV-SR：使用单枚紫杉醇洗脱支架治疗新发病变冠状动脉疾病）。
JACC Cardiovasc Interv. 2009 Dec;2(12):1248-59. doi: 10.1016/j.jcin.2009.10.003.
3
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).在新发冠状动脉病变患者中，与紫杉醇洗脱支架相比，依维莫司洗脱支架的安全性、疗效和成本效益：来自 ENDEAVOR IV 试验的 2 年随访结果（美敦力 Endeavor 药物[ABT-578]洗脱冠状动脉支架系统与紫杉醇洗脱 Taxus 冠状动脉支架系统在新发原生冠状动脉病变中的随机对照试验）。
JACC Cardiovasc Interv. 2009 Dec;2(12):1208-18. doi: 10.1016/j.jcin.2009.10.008.
4
Medicare and medical technology--the growing demand for relevant outcomes.医疗保险与医疗技术——对相关结果的需求不断增长
N Engl J Med. 2010 Feb 4;362(5):377-9. doi: 10.1056/NEJMp0912062. Epub 2010 Jan 20.
5
Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices.美国食品和药物管理局在心血管设备上市前批准中检查的研究证据的强度。
JAMA. 2009 Dec 23;302(24):2679-85. doi: 10.1001/jama.2009.1899.
6
Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model.血管内支架治疗腹主动脉瘤：系统评价和经济模型。
Health Technol Assess. 2009 Oct;13(48):1-189, 215-318, iii. doi: 10.3310/hta13480.
7
Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods.阴道脱垂修复与中段尿道吊带术（OPUS）试验的结果——设计与方法
Clin Trials. 2009 Apr;6(2):162-71. doi: 10.1177/1740774509102605.
8
Spinal cord stimulation for patients with failed back surgery syndrome: a systematic review.脊髓刺激治疗腰椎手术失败综合征患者：一项系统评价。
Pain Physician. 2009 Mar-Apr;12(2):379-97.
9
The Medical Device Safety Act of 2009.2009年医疗器械安全法案。
N Engl J Med. 2009 Apr 9;360(15):1550-1. doi: 10.1056/NEJMe0902377. Epub 2009 Mar 18.
10
Medical errors in orthopaedics. Results of an AAOS member survey.骨科医疗差错。美国骨科医师学会成员调查结果。
J Bone Joint Surg Am. 2009 Mar 1;91(3):547-57. doi: 10.2106/JBJS.G.01439.
Zotero 插件